Myosin Va transports intracellular cargoes along actin filaments in cells 1 . This processive, two-headed motor takes multiple 36-nm steps in which the two heads swing forward alternately towards the barbed end of actin driven by ATP hydrolysis 2 . The ability of myosin Va to move processively is a function of its long lever arm, the high duty ratio of its kinetic cycle and the gating of the kinetics between the two heads such that ADP release from the lead head is greatly retarded [3] [4] [5] [6] [7] [8] [9] [10] . Mechanical studies at the multiple-and the single-molecule level suggest that there is tight coupling (that is, one ATP is hydrolysed per power stroke), but this has not been directly demonstrated 4, 5, 11 . We therefore investigated the coordination between the ATPase mechanism of the two heads of myosin Va and directly visualized the binding and dissociation of single fluorescently labelled nucleotide molecules, while simultaneously observing the stepping motion of the fluorescently labelled myosin Va as it moved along an actin filament. Here we show that preferential ADP dissociation from the trail head of mouse myosin Va is followed by ATP binding and a synchronous 36-nm step. Even at low ATP concentrations, the myosin Va molecule retained at least one nucleotide (ADP in the lead head position) when moving. Thus, we directly demonstrate tight coupling between myosin Va movement and the binding and dissociation of nucleotide by simultaneously imaging with near nanometre precision.
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The ability to visualize the binding of fluorescent nucleotides to myosin in the light microscope has been limited by technical problems, such as the nonspecific binding of the fluorescent nucleotide to the coverslip, low quantum yield and rapid photobleaching. This has limited the maximum nucleotide concentration that could be used with analogues such as Cy3-labelled ATP to less than 100 nM [12] [13] [14] [15] . To overcome these problems, we have used a fluorescent ATP analogue (39-(7-diethylaminocoumarin-3-carbonylamino)-39-deoxyadenosine-59-triphosphate; deac-aminoATP), in which the fluorescence emission increases ,25-fold ( Supplementary Fig. 1 ) when bound to a heavy meromyosin-like fragment of myosin Va (MyoV-HMM) in solution 16, 17 . The kinetic mechanism of MyoV-HMM using deacaminoATP as a substrate has been thoroughly studied, including the extent of gating that occurs between the two heads during movement 10, 17 . In brief, deac-aminoATP binds 3-fold faster to MyoV than ATP does, and deac-aminoADP dissociates 10-20-fold slower than ADP 17 . When MyoV-HMM is bound to actin by both heads, the release rate of deac-aminoADP from the lead head is decreased by about 30-fold compared to the unstrained rate 10 . The processive run length of MyoV-HMM on actin using deac-aminoATP as a substrate is shorter (1,050 6 80 nm) than when using ATP alone (1,950 6 160 nm) (Supplementary Figure 2a) . The maximal velocity of movement on actin at saturating deac-aminoATP is 120 nm s
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, approximately 8-10-fold less than observed with ATP 10 ( Supplementary Fig. 2b ). Deac-aminoADP that was non-specifically bound to a coverslip surface in the absence of MyoV-HMM was visualized using an electron multiplying charged coupled device (EMCCD) camera at a camera gain level of 1,000 (the scale for gain is 0-1,000; Fig. 1a, e) . The gain on the camera chip was then reduced to 400, at which the intensity of the nonspecifically bound deac-aminoADP spots was considerably reduced (Fig. 1b, f) . However, at the same gain (400) and collection time of 330 ms, deac-aminoADP that was bound to MyoV-HMM on the coverslip (Fig. 1c, g ) had a sufficiently high intensity (.10,000 photons) to fit the point-spread function of a single spot and so determine its precise nanometre localization 18 ( Supplementary Fig. 3 ). At the single-molecule level, we found a 4-fold enhancement of the fluorescent intensity of deac-aminoADP on binding to MyoV-HMM.
We exchanged Alexa-Fluor-568-labelled calmodulins for the endogenous calmodulin bound to the neck region of MyoV-HMM. On average, each calmodulin contained 1.8 Alexa Fluor 568 moieties, and three Alexa-Fluor-568-labelled calmodulins were exchanged per MyoV-HMM, making it much brighter than myosin fused to GFP molecules or containing a single Cy3-or rhodamine-labelled calmodulin that had been previously used for single-molecule studies 3, 18 . Similar estimates for labelling ratios were obtained by using spectrophotometric techniques in solution or by examining the photobleaching kinetics of the molecules in the microscope ( Supplementary Fig. 4 ). This allowed the Alexa-Fluor-568-MyoV-HMM to be as bright as the deac-aminonucleotides, and permitted the same camera and camera settings to be used to image both (Fig. 1d, h and Supplementary Fig. 3 ).
We simultaneously visualized Alexa-Fluor-568-MyoV-HMM and deac-aminonucleotide during processive movement on actin filaments in vitro ( Fig. 2a, b; Supplementary Fig. 5 and Supplementary Movie). The Alexa-Fluor-568-MyoV-HMM and the deacaminonucleotide fluorescence moved in the same direction at the same rate and on the same actin filaments (Fig. 2a, b and Supplementary Figs 5 and 6 ). The fluorescent signal from AlexaFluor-568-MyoV-HMM moved in 36-nm steps as would be expected from a molecule, in which both heads were labelled (Fig. 2a) , albeit there is the possibility of minor differences between the alternating step sizes due to unevenness in the labelling of the two heads (see Supplementary Fig. 7 for an example of 'limping' movement). The deac-aminonucleotide moved in 18-nm steps. One step occurred simultaneously with the MyoV-HMM step, whereas the other step occurred during a dwell in the MyoV-HMM movement (Fig. 2b) . These observations from a single trace are reinforced by examining histograms of the MyoV-HMM step size (which shows a peak of 36 6 7 nm; Fig. 2d ) and of the deac-aminonucleotide step size (which shows two peaks of 18 6 7 nm and 36 6 9 nm; Fig. 2e ). The larger, 36 nm values for the deac-aminonucleotide movement are expected to result when two 18-nm movements occurred without a discernable dwell between them. This is calculated to occur 22-37% of the time (1-e 2kt ) on the basis of the deac-aminonucleotide association and dissociation rate constants measured in Fig. 3 and the 330 ms data acquisition time. The intensity of the deac-aminonucleotide signal integrated from a 12 3 12 pixel (840 3 840 nm 2 ) area surrounding the molecule at each frame showed a bimodal distribution in which one peak contained a factor of two more photons per frame than the other (Supplementary Fig. 8 ). The photon count in the smaller peak represents one deac-aminonucleotide per MyoV-HMM, whereas that in the other represents two per MyoV-HMM. Note that this nucleotide has similar fluorescence intensity when bound as MyoV-HMM-ADP, MyoV-HMM-ADP-P i or MyoV-HMM-ATP, and thus, we cannot discriminate between different nucleotide states of a single head by intensity 17 . Using this criterion, the normalized intensity of the deac-aminonucleotide signal was also plotted as a function of time (Fig. 2c) and was shown to change from a value of one to two during each MyoV-HMM step and then decrease from a value of two to one during the MyoV-HMM dwell period.
The model to account for the 36-nm Alexa-Fluor-568-MyoV-HMM steps and the 18-nm deac-aminonucleotide steps is shown in Fig. 2f . Initially, MyoV-HMM has deac-aminoADP bound to both heads and the position of the Alexa-Fluor-568-MyoV-HMM and the deac-aminonucleotide spots are coincident (step 1). DeacaminoADP is then released from the trail head, which results in the position of the deac-aminonucleotide signal advancing by 18 nm x a x is (p ix e l) y a x is (p ix e l)
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(step 2). After deac-aminoATP binds to the nucleotide-free trailing head, this head rapidly dissociates and swings forward to rebind and become the new lead head (steps 3 and 4). Single-molecule and bulk solution studies suggest that the time between detachment of the trailing head, followed by its forward swing and reattachment, is a few milliseconds and is thus much faster than the sampling rate (330 ms) used in our experiments 7, 10, 11, 19 . Therefore, ATP binding to the trail head, dissociation of that head, and stepping and rebinding are all associated with a 36-nm movement of the MyoV-HMM molecule and a simultaneous 18-nm movement of the deac-aminonucleotide signal. The binding of deac-aminoATP to the trail head might be expected to produce a transient backward movement of the nucleotide fluorescence centroid, but this is not seen because the trail head quickly detaches and is rapidly moved forward by the power stroke occurring on the lead head.
To confirm the model, lifetimes during the two and one deacaminonucleotide signal levels were analysed at three different deacaminoATP concentrations (Fig. 3) . We interpret the two to one nucleotide signal decrease to be associated with deac-aminoADP release from the trail head, whereas the one to two nucleotide signal increase is associated with deac-aminoATP binding to that head. Thus, fitting the lifetimes of the high nucleotide signal at 100, 200
and Fig. 3a-c) . This is similar to the deac-aminoADP dissociation rate constants measured in solution under identical conditions using stopped-flow spectrofluorimetry (1.2 s 21 ; Supplementary Fig. 9c ). This would indicate that in our experiments there is no acceleration of the deac-aminoADP release from the trail head and is consistent with stopped-flow kinetic results previously reported 10 . An acceleration of the ADP release rate from a positively strained trail head of up to 50-fold was previously predicted if the lead head were to complete its power stroke when both heads were attached 9 . However, an earlier study found that the lead heads were only at the start of their power stroke 20 , which is consistent with the lack of acceleration of ADP release from the rear head observed in our study. On the other hand, the observed deac-aminoATP binding rates determined by fitting the lifetimes of the low signal level intermediate increased as the deac-aminoATP concentration used was raised from 100 to 200 to 400 nM (0. Fig. 3d-f) . This corresponds to a second order association rate constant of Supplementary Fig. 9b) .
These results support a model in which the trailing head of the MyoV-HMM molecule releases ADP much more rapidly than the leading head 2, 9, 10 . In fact, solution kinetics studies at 20 uC demonstrated that the deac-aminoADP dissociation rate (0.48 s 21 ) from the (presumably) trailing head was 32-times faster than that of the leading head (0.015 s 21 ) and a similar mechanism occurs with ADP 10,21 . Inhibition of ADP dissociation from the lead head is thought to be essential for long processive movements. Our results indicate that the main pathway of the MyoV-HMM ATPase is by the central shaded line of intermediates in Fig. 4 . The recently detached (formerly rear) head containing ATP or ADP-P i rapidly swings forward to the leading position where it binds actin (state (1)). On binding to actin, this head quickly releases P i (state (1) to (2) in Fig. 4 . Note the non-zero intercept which is also present in the solution kinetic measurements of deac-aminoATP binding to acto-HMM in Supplementary Fig. 9 . A non-zero intercept is predicted by modelling the kinetic mechanism and is seen in some published studies 5 but is not readily observed because of the large extrapolation from the high nucleotide concentrations typically used in kinetic studies. The horizontal line through the deac-aminoADP dissociation data represents the average of the mean value for the three nucleotide concentrations (0.86 s 21 ).
dissociates from the trailing head (state (2) to (3)) which allows a new ATP to bind. This results in a rapid detachment of that head, allowing the lead head to undergo its power stroke and repositioning the detached head to become the new lead head (state (3) to (4)). This model accounts for the 36-nm forward steps taken by the AlexaFluor-568-MyoV-HMM that occur coincidently with the 18-nm movement and a doubling of the intensity of the nucleotide fluorescence. An 18-nm backward step of nucleotide fluorescence would occur if deac-aminoADP dissociated first from a lead head (state (2) to (C)). We did not observe such steps, which attest to the high level of strain-dependent gating between the kinetics of the two heads of MyoV-HMM. Termination of runs principally occurs by the route (1) to (A) to (B). This is consistent with most termination cases in which the myosin has only one deac-aminonucleotide bound.
Here we have directly observed the substrate binding and product dissociation steps of single motors moving along their tracks. The data show the relationship between these steps and the mechanism of processive movement of myosin Va on actin. These observations directly demonstrate that, as previously proposed, myosin Va is a tightly coupled motor 2, [4] [5] [6] [7] [8] [9] [10] [11] 19 . Each step in a processive run involves the binding of an ATP molecule to the trail head of the myosin Va, which is rapidly followed by a 36-nm step along the actin and subsequently by the dissociation of ADP from the trail head. DeacaminoATP should be a useful analogue for other single-molecule studies such as combined optical trapping and total internal reflection fluorescence (TIRF) microscopy.
METHODS SUMMARY
Protein purification and labelling. Mouse MyoV-HMM, MyoV-S1 and calmodulin were purified as previously described 22 . Calmodulin was labelled with Alexa Fluor 568 and exchanged for endogenous calmodulins into MyoV-HMM in a similar method to that previously described 3, 22 . Data acquisition and analysis. The single molecule in vitro motility assay was carried out essentially as previously described 22 . Dual imaging of deac-aminonucleotide and Alexa-Fluor-568-labelled MyoV-HMM were conducted using an Olympus IX81 microscope equipped for two fibre optic input cables using the DualView system 23 . Images were taken at a frame rate of 330 ms and the position of each fluorescent spot was determined using the FIONA method 18 .
Transient kinetic data. Measurement of the deac-aminoATP binding and deacaminoADP dissociation were performed on a KinTek stopped-flow spectrofluorimeter as previously described 10, 17 .
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METHODS
Preparation of proteins. Mouse MyoV-HMM and MyoV-S1 were purified from Sf9 cells after infection with baculoviruses driving the expression of the HMM (or S1) and calmodulin 24 . Calmodulin was purified from bovine testes and labelled with Alexa Fluor 568 succimidyl ester (Invitrogen) 22 . The molar ratio of Alexa Fluor 568 per calmodulin was determined to be 1.8 from the absorbance in solution and a molar extinction coefficient of 91,300 M -1 cm 21 for Alexa Fluor 568 and e 0.1% 5 0.18 at 280 nm for calmodulin. The labelled calmodulin (molar ratio of 20 per MyoV-HMM) was exchanged with endogenous calmodulin as previously described 22 . This resulted in an average of six Alexa Fluor 568 dyes per MyoV-HMM, as determined spectrophotometrically. This value was confirmed by comparing the intensity of single Alexa Fluor 568 molecules bound nonspecifically to a surface (2,000 a.u.) with that of the average intensity of Alexa-Fluor-568-MyoV-HMM (12,000 a.u.). Biotinylated actin and biotinylated BSA were prepared 22 and deac-aminoATP and deac-aminoADP were synthesized as described previously 25 . Emission and excitation spectra of 0.5 mM deac-aminoADP in the presence and absence of 1 mM MyoV-HMM were taken with a Fluoromax-3 spectrofluorimeter (HORIBA Jobin Yvon, NJ) using 2 nm slits. Two-line total internal reflection fluorescence microscopy. Alexa-Fluor-568-labelled MyoV-HMM and deac-aminoATP were observed by objective-type TIRF microscopy using an Olympus IX81 microscope and a 360, 1.45 numerical aperture PlanApo objective lens with two magnifying (relay) lenses (31.6 in the microscope and 32.5 in front of the camera). The temperature was kept at 25 uC with an environmental box (Precision plastics). To visualize two colours of fluorescence simultaneously, we used the 568 nm line from an Ar-Kr Laser (model I70C, Spectra physics) for Alexa Fluor 568 and the 442 nm line from a He-Cd Laser (model IK41711-G, KIMMON) for deac-aminoATP. Both laser lines were combined by an acousto-optical tunable filter (Prairie Technologies), which also controlled the laser power. After the acousto-optical tunable filter, the two laser lines were separated by a dichroic mirror onto optical fibres. This allows both wavelengths to be in focus at the same time. The two fibres are guided to individual TIRF illuminators located at the rear end of the microscope. Illumination at 442 nm was by the Olympus TIRF apparatus and the illumination at 568 nm was by the position usually occupied by the mercury arc lamp housing. The two laser lines from the two illuminators were combined with a dichroic mirror and introduced into the objective lens. The power of both the 442 nm and 568 nm beams was 10 mW to 20 mW in front of the objective lenses. The emitted light was passed through a dual line dichroic mirror (442/568, Chroma) and split by a dichroic mirror (552dcr, Chroma) in the Dual-View system (Optical Insights). Fluorescence was detected by an EMCCD camera (DV897, 512BV, Andor technology), at 290 uC with a gain of either 400 or 1,000. Images were digitized by using Metamorph (MSD/Molecular Device ver.7.1). Intensity measurement of deac-aminoADP bound either to the surface or to MyoV-HMM. To test whether the fluorescence of deac-aminoADP increased in intensity upon binding to MyoV-HMM in the microscope, we directly observed single molecules of deac-aminoADP in the presence and absence of MyoV-HMM.
First, 10 pM deac-aminoADP was added into a flowcell coated with 0.1% nitrocellulose and incubated for 2 min at room temperature. Free deac-aminoADP was washed out using motility assay buffer (40 mM KCl, 20 mM MOPS, 4 mM MgCl 2 , 0.1 mM EGTA, 1 mM calmodulin, and 50 mM DTT, pH 7.5, 25 uC). The solutions also included an oxygen scavenging system composed of 25 mg ml 21 glucose oxidase, 45 mg ml 21 catalase and 2.5 mg ml 21 glucose. Deac-aminoADP was imaged at 442 nm using the TIRF microscopy set up described above at EMCCD camera gains of 1,000 (Fig. 1a, e) and 400 (Fig. 1b, f) ; images were acquired in 330 ms windows. On a second slide, 10 pM MyoV-HMM was added into the flowcell and incubated for 2 min at room temperature. Free MyoV-HMM was washed out using motility assay buffer. Deac-aminoADP (10 nM) was added into the flowcell and the sample was imaged at 442 nm and 568 nm at the same two camera gains. Under these conditions at the single-molecule level in the microscope, the intensity of deac-aminoADP increased 4 fold upon binding to MyoV-HMM compared to the 25 fold change in solution. Single-molecule motility assay and data analysis. Single-molecule motility assays were performed as previously described 26 . Position data for AlexaFluor-568-MyoV-HMM and deac-aminoATP were analysed by FIONA 18 . The integrated intensities of 15 3 15 pixel areas were measured at the indicated concentrations using Metamorph. To observe single-molecule movements of MyoV-HMM and deac-aminoATP simultaneously, we changed the concentration of Alexa-Fluor-568-MyoV-HMM to reduce background. At 100 nM and 200 nM deac-aminoATP concentrations, 200 pM Alexa-Fluor-568-MyoV-HMM was used, whereas at 400 nM deac-aminoATP, 4 pM Alexa-Fluor-568-MyoV-HMM was used. Steps were identified by eye and marked by hand.
Run lengths of Alexa-Fluor-568-MyoV-HMM were measured with either 1 mM ATP or 1 mM deac-aminoATP. Actin filaments were labelled with 10% AlexaFluor-488-phalloidin and 90% phalloidin. The determination of run length was performed as described previously 22 , except that only myosin molecules that dissociated before reaching the end of actin filaments were scored. The average length of an actin filament was 12.5 mm. Velocities with various deac-aminoATP concentrations were measured by time lapse in which data were taken at 10 s intervals with a 300 ms exposure time. Sequential images were taken to analyse velocity. Determination of number of photons. We determined the number of photons from the integrated intensity of a 10 3 10 pixel image of each chosen spot. DeacaminoADP was bound nonspecifically to the surface or to MyoV-HMM, which was bound on a nitrocellulose-coated surface. The estimated total number of photons in the spot at various camera gains was calculated as previously described 27 . Alternatively, the number of photons, n, was calculated using an equation n~60:14 I/a provided by Andor Technology (data not shown) in which 60.14 is the camera sensitivity at 10 MHz, electron multiplying amplifier, 31.0 preamp setting (electron per A/D count), a is the percentage of quantum efficiency of the camera at the appropriate wavelength, and I is the detected integrated intensity. Results obtained by the two methods gave reasonable agreement. At least 10,000 photons are required to obtain 2.5 nm localization 19 . Determination of localization accuracy from single-molecule fluorophores has been calculated by theoretical equations 27 and measured experimentally 18 .
